Brightflow
Develops a percutaneous, long-lasting right ventricular support pump for patients with right heart failure; still preclinical
Highlights
- New on EvolcAdded 2026-11-02
About Brightflow
Brightflow is a French medtech company developing a percutaneous, long-lasting right ventricular (RV) support device for patients with right heart failure. The device is under preclinical development and not yet available for human use, and the company is preparing first-in-human trials. Brightflow holds EMA Orphan Device designation (OD/EMA/EX/0000281308) for isolated RV dysfunction and Fontan circulation failure.
The device is intended for patients with right ventricular dysfunction, including those with end-stage heart failure for whom existing minimally invasive treatments offer only temporary relief. Its audience is physicians and patients with right heart disease. The company does not sell the device yet.
Brightflow was founded in 2020 by cardiologist Pascal Lim, who serves as President and CEO. Its registered seat is in Orléans and it is based in Paris. The company reports a team of 30 full-time engineers and is supported by a strategic partner and life science venture capital firms.
Product: Percutaneous, long-lasting right ventricular support device for right heart failure, in preclinical development.
Jobs at Brightflow
Leadership
- Pascal Lim · Founder - President & CEOSource: company website
- Brice Epry · Chief Financial Officer (CFO)Source: company website
- Lars Bredenbreuker · Chief Technology Officer (CTO)Source: company website
More health & medtech companies
Cairdac
Develops autonomous leadless pacemakers for cardiac patients and healthcare professionalsNew on EvolcCallyope
Clinical AI software for mental health clinicians to document care and monitor patient symptomsYoung companyNew on EvolcCalmedica
Patient remote-monitoring software (SMS/RCS chatbot, decision-support) for hospitals and clinics in FranceNew on EvolcCaptainvet
Online veterinary appointment booking for pet owners and appointment-management tools for veterinary practices in FranceNew on EvolcCardiametrics
Predictive heart failure monitoring using a subcutaneous sensor for patients at home and their cardiac care teamsYoung companyNew on EvolcCardiawave
Non-invasive ultrasound device for treating calcific aortic stenosis, for cardiac centres and patients ineligible for valve replacementNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Privacy & consent
- CookieYesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.